Brockhaus Technologies And Two More German Exchange Growth Stocks With High Insider Ownership

As global markets respond to shifting economic indicators, Germany's DAX index has shown resilience, gaining 1.48% this week. This positive momentum in the German market underscores a growing investor confidence that could be particularly beneficial for growth companies with high insider ownership. In such an environment, stocks where insiders hold significant stakes may offer potential advantages, as these stakeholders often have a deep commitment to the company’s long-term success.

Top 10 Growth Companies With High Insider Ownership In Germany

Name	Insider Ownership	Earnings Growth
pferdewetten.de (XTRA:EMH)	26.8%	75.4%
Deutsche Beteiligungs (XTRA:DBAN)	39.1%	31.6%
YOC (XTRA:YOC)	24.8%	21.8%
NAGA Group (XTRA:N4G)	14.1%	74.7%
Exasol (XTRA:EXL)	25.3%	105.4%
Alelion Energy Systems (DB:2FZ)	37.4%	106.6%
Stratec (XTRA:SBS)	30.9%	21.9%
elumeo (XTRA:ELB)	25.8%	99.1%
Redcare Pharmacy (XTRA:RDC)	17.7%	47.4%
Friedrich Vorwerk Group (XTRA:VH2)	18%	30.4%

Click here to see the full list of 17 stocks from our Fast Growing German Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Brockhaus Technologies (XTRA:BKHT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Brockhaus Technologies AG operates as a private equity firm with a market capitalization of approximately €304.03 million.

Operations: The firm's revenue is primarily derived from its Financial Technologies and Security Technologies segments, generating €153.43 million and €39.43 million respectively.

Insider Ownership: 26.6%

Brockhaus Technologies, trading at a significant discount to its estimated fair value, is poised for notable growth. The company's revenue is expected to increase by 17.8% annually, outpacing the German market's 5.4%. Although currently unprofitable with a net loss of €1.38 million in Q1 2024, it is forecasted to reach profitability within three years with an anticipated earnings growth of 74.21% per year. However, its projected return on equity remains modest at 10.3%.

• Dive into the specifics of Brockhaus Technologies here with our thorough growth forecast report.
• Our valuation report here indicates Brockhaus Technologies may be undervalued.

Hypoport (XTRA:HYQ)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Hypoport SE is a technology-based financial service provider in Germany, with a market capitalization of approximately €2.07 billion.

Operations: The company generates revenue primarily through its Credit Platform and Insurance Platform, with respective earnings of €155.60 million and €66.29 million.

Insider Ownership: 35.1%

Hypoport SE, a growth-oriented company with high insider ownership in Germany, reported a significant increase in Q1 2024 earnings to €3.04 million from €0.503 million year-over-year, with sales rising to €107.47 million. Despite a low forecast return on equity of 9.1% in three years, Hypoport's revenue and earnings are expected to outperform the German market, growing at 13.4% and 31.9% per year respectively. The firm's recent presentation at the Berenberg European Conference highlighted these robust financial improvements and optimistic growth projections.

• Navigate through the intricacies of Hypoport with our comprehensive analyst estimates report here.
• According our valuation report, there's an indication that Hypoport's share price might be on the expensive side.

Redcare Pharmacy (XTRA:RDC)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Redcare Pharmacy NV is a company that operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market capitalization of approximately €2.85 billion.

Operations: The company generates revenue primarily through its operations in the DACH region (€1.62 billion) and other international markets (€0.37 billion).

Insider Ownership: 17.7%

Redcare Pharmacy, positioned in the high-growth sector with substantial insider ownership in Germany, is on a trajectory to achieve profitability within three years, aligning with above-market average growth expectations. Despite trading at 71.8% below its estimated fair value and experiencing high share price volatility recently, the company reported a strong first quarter with sales rising to €560.22 million from €372.05 million year-over-year. However, shareholders have faced dilution over the past year, and the forecasted return on equity remains low at 7.5%.

• Take a closer look at Redcare Pharmacy's potential here in our earnings growth report.
• Insights from our recent valuation report point to the potential overvaluation of Redcare Pharmacy shares in the market.

Seize The Opportunity

• Navigate through the entire inventory of 17 Fast Growing German Companies With High Insider Ownership here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com